Clinical Stage Oncology Co. For Early Cancer Detec
Chicago, IL Cook County
Request More Information Contact the Seller
- RE: Clinical Stage Oncology Co. For Early Cancer Detec
- Contact: Rick Carlson
- License #: 1820673
Quick Facts
| Asking Price: | Not Disclosed | |
| Annual Revenue: | $9,498 | |
| Net Profit: | Not Disclosed | |
| Cash Flow: | $1,091 | |
| Total Debt: | Not Disclosed | |
| FF&E: | Not Disclosed | |
| Real Estate: | Not Disclosed | |
| Year Established: | 2017 | |
| Employees: | 8 | |
| BBN Listing #: | 999543 | |
| Broker Reference #: | 1440 ONCOLOGY |
Business Overview:
The Company is a clinical-stage oncology company with a platform that combines biospectral impedance and AI/ML for point-of-care cancer detection. The lead product delivers rapid, in-procedure assessment of surgical margins—identifying the presence and location of cancer within minutes. Initial commercialization targets skin cancer, where the lead product can shorten procedures, spare healthy tissue, improve surgeon economics, and enhance outcomes. The Company has also built a compelling breast cancer dataset and plans to deploy the lead product to help dramatically reduce the ~20–25% re-surgery (re-excision) rate in partial mastectomies; the breast program is in line for non-dilutive CPRIT support.
The Company has a collaboration with PHC Holdings (formerly Panasonic Healthcare; TSE:6529) to commercialize the lead product. The company anticipates FDA clearance in 2026 and profitability in 2028.
Beyond skin and breast, the Company has generated promising data in lung, pancreatic, esophageal, and colon tissue. Follow-on products include a rapid biopsy-assessment device and a needle-based device leveraging the same platform.
Use of Proceeds: This round will fund FDA clearance activities and the initial commercial launch of the lead product.
NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Contact the Seller:
To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button (above Quick Facts) and when you are done searching and have made all your selections, simply click on the REQUEST FREE INFO button at the bottom of this page.
Property Features and Assets:
Facilities: Leased
Market Competition and Expansion:
Competition: The Company is well-positioned: offering a technology type (bioelectric / impedance + AI) that is one of the promising directions in margin detection, with some advantages in potential cost, portability, and multi-tissue applicability.
Growth & Expansion: The Company has already taken several concrete steps that are helping it scale / expand. Some of the key ones: strategic partnerships and distribution agreements, approaching product launch timeline as well as development of highly experienced advisors.
Reason for Selling:
Raise capital to secure FDA clearance and launch. Kindly ask the seller for more information.
Additional Details:
- The property is Leased.
- The owner is willing to train/assist the new owner.
- This is not homebased business opportunity.
- This is not a franchise resale opportunity
Documents:
Relevant Links:
- View more Illinois businesses for sale
- View more Businesses For Sale in the same industry
- Sell a business online
- Find a business broker
Request More Information
